Table 1.

ROI characteristics

Patient ID	Patient age [y]	PSA [ng/mL]	ROI ID	Slice (No/14)	No of voxels (Acquisition 2)	Likert (No/5)	Prostate zone	Gleason score (if known)	Biopsy type	ROI group ID
1	63	10.2	1	9	26 (8)	3	PZ	benign	targeted 25/09/2016	1
			2	9	59 (55)	4	PZ	3 + 4		2
			3	9	28 (25)	2	TZ	N/A		3
			4	11	71 (89)	4	TZ	benign		4
2	66	4.7	5	8	10 (10)	2	PZ	N/A	targeted 18/07/2016	5
			6	7	16 (17)	4	PZ	3 + 3		6
			7	7	25 (26)	2	TZ	N/A		3
			8	7	42 (39)	4	TZ	3 + 4		7
3	67	4.86	13	5–6	109 (108)	5	PZ	3 + 4	targeted 31/06/2017	2
			14	8	26 (25)	3	PZ	3 + 3		6
			15	8	28 (26)	2	TZ	N/A		3
			16	8	60 (66)	4	TZ	3 + 3		8
4	73	10.20	9	8	48	2	PZ	benign	targeted 06/10/2016	1
			10	6	29	5	PZ	3 + 4		2
			11	7	16	4	PZ	3 + 4		2
			12	7	27	2	TZ	benign		4
5	49	6.7	17	7	25	2	PZ	benign	TRUS 27/05/2010	1
			18	7	26	2	TZ	benign		4
6	57	4.04	19	8	25	2	PZ	N/A	targeted 04/11/2016.	5
			20	6	29	2	TZ	N/A		3
			21	6	37	4	TZ	3 + 3		8
			22	8	125	2	CZ	N/A		9
7	52	11.1	23	7	26	3	PZ	benign	prostatectomy 02/11/2016	1
			24	6–7	133	5	PZ	4 + 3		10
			25	8	26	2	TZ	3 + 4		7
8	64	6.03	26	11	35	2	PZ	benign	targeted 30/09/2016	1
			27	8	10	4	PZ	benign		1
			28	9	33	2	TZ	benign		4

TRUS, transrectal ultrasound.